The Neuropsychiatric Inventory: assessing psychopathology in dementia patients.
Cummings JL.
Neurology. 1997 May;48(5 Suppl 6):S10-6. doi: 10.1212/wnl.48.5_suppl_6.10s.
High-resolution EEG.
Michel CM.
Handb Clin Neurol. 2019;160:185-201. doi: 10.1016/B978-0-444-64032-1.00012-6.
The Neuropsychiatric Inventory-Diary Rating Scale (NPI-Diary): A Method for Improving Stability in Assessing Neuropsychiatric Symptoms in Dementia.
Morganti F, Soli A, Savoldelli P, Belotti G.
Dement Geriatr Cogn Dis Extra. 2018 Sep 10;8(3):306-320. doi: 10.1159/000490380. eCollection 2018 Sep-Dec.
Reading Covered Faces.
Pavlova MA, Sokolov AA.
Cereb Cortex. 2022 Jan 10;32(2):249-265. doi: 10.1093/cercor/bhab311.
Reactive hypoglycemia.
Hofeldt FD.
Endocrinol Metab Clin North Am. 1989 Mar;18(1):185-201.
Revised Temperament and Character Inventory factors predict neuropsychiatric symptoms and aging-related cognitive decline across 25 years.
Ronat L, Rönnlund M, Adolfsson R, Hanganu A, Pudas S.
Front Aging Neurosci. 2024 Feb 21;16:1335336. doi: 10.3389/fnagi.2024.1335336. eCollection 2024.
Technology-assisted interventions for neuropsychiatric disorders.
Fliti T, Shhaytli A, Serhal A, Takesh Z, Chokor M.
Prog Brain Res. 2025;298:241-269. doi: 10.1016/bs.pbr.2025.08.017. Epub 2025 Sep 5.
Brain-machine interfaces from motor to mood.
Shanechi MM.
Nat Neurosci. 2019 Oct;22(10):1554-1564. doi: 10.1038/s41593-019-0488-y. Epub 2019 Sep 24.
Neuropsychiatric Symptoms in Posterior Cortical Atrophy and Alzheimer Disease.
Suárez-González A, Crutch SJ, Franco-Macías E, Gil-Néciga E.
J Geriatr Psychiatry Neurol. 2016 Mar;29(2):65-71. doi: 10.1177/0891988715606229. Epub 2015 Sep 24.
Navigating the FDA regulatory landscape.
Scott PD, Bajaj A, McMullen DP.
Neuropsychopharmacology. 2024 Jan;49(1):18-22. doi: 10.1038/s41386-023-01723-z. Epub 2023 Oct 18.
